E Fund Management »

Alnylam Pharmaceuticals shares owned by E Fund Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by E Fund Management from 13F filings

Historical chart of E Fund Management investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by E Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by E Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $132k 389 339.11

More positions owned by E Fund Management

Yum China Holdings (YUMC)
PDD Holdings Sponsored Ads (PDD)
iShares Core S&P 500 ETF Core S&p500 Etf (IVV)
State Street SPDR S&P 500 ETF Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Agnico (AEM)
Newmont Mining Corporation (NEM)
Microsoft Corporation (MSFT)
Barrick Mining Corp Com Shs (B)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)

View all positions for E Fund Management

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
State Street Corporation
Geode Capital Management
Baillie Gifford & Co
Norges Bank Investment Management
Invesco
Dodge & Cox
Wellington Management Company
T. Rowe Price Investment Management
Orbis Allan Gray

View all funds holding Alnylam Pharmaceuticals